Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tejas M Dhameliya

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Molecular Diversity|February 8, 2022
Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulationsTejas M Dhameliya, Prinsa R Nagar, Normi D Gajjar
Journal of Molecular Structure|April 27, 2021
In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysisNormi D Gajjar, Tejas M Dhameliya, Gaurang B Shah
Journal of Molecular Structure|August 2, 2021
In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysisPrinsa R Nagar, Normi D Gajjar, Tejas M Dhameliya
Bioorganic Chemistry|January 7, 2025
Recent advancements in the quest of benzazoles as anti-Mycobacterium tuberculosis agentsKshitij I Patel, Nirjhar Saha, Tejas M Dhameliya, et al.
Current Medicinal Chemistry|November 10, 2015
Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future PerspectivesPradeep S Jadhavar, Maulikkumar D Vaja, Tejas M Dhameliya, et al.
Molecular Diversity|January 5, 2022
A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agentsTejas M Dhameliya, Shrddhaba J Chudasma, Tanvi M Patel, et al.
3 Biotech|March 8, 2024
In silico investigation of potential phytoconstituents against ligand- and voltage-gated ion channels as antiepileptic agentsPunam Salaria, N N Subrahmanyeswara Rao, Tejas M Dhameliya, et al.
European Journal of Medicinal Chemistry|April 30, 2023
Comprehensive coverage on anti-mycobacterial endeavour reported during 2022Tejas M Dhameliya, Drashtiben D Vekariya, Heta Y Patel, et al.
Archiv Der Pharmazie|December 12, 2025
Recent Advancements and Developments of Anti-Malarial Agents Reported in 2023Palak K Vadodariya, Shahnaz Alom, Anu Sharma, et al.
Future Medicinal Chemistry|November 29, 2022
Benzo[<i>d</i>]thiazole-2-carboxamides as new antituberculosis chemotypes inhibiting mycobacterial ATP phosphoribosyl transferaseTejas M Dhameliya, Rishu Tiwari, Arkaprabha Banerjee, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Molecular Diversity|February 8, 2022
Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulationsTejas M Dhameliya, Prinsa R Nagar, Normi D Gajjar
Journal of Molecular Structure|April 27, 2021
In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysisNormi D Gajjar, Tejas M Dhameliya, Gaurang B Shah
Journal of Molecular Structure|August 2, 2021
In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysisPrinsa R Nagar, Normi D Gajjar, Tejas M Dhameliya
Bioorganic Chemistry|January 7, 2025
Recent advancements in the quest of benzazoles as anti-Mycobacterium tuberculosis agentsKshitij I Patel, Nirjhar Saha, Tejas M Dhameliya, et al.
Current Medicinal Chemistry|November 10, 2015
Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future PerspectivesPradeep S Jadhavar, Maulikkumar D Vaja, Tejas M Dhameliya, et al.
Molecular Diversity|January 5, 2022
A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agentsTejas M Dhameliya, Shrddhaba J Chudasma, Tanvi M Patel, et al.
3 Biotech|March 8, 2024
In silico investigation of potential phytoconstituents against ligand- and voltage-gated ion channels as antiepileptic agentsPunam Salaria, N N Subrahmanyeswara Rao, Tejas M Dhameliya, et al.
European Journal of Medicinal Chemistry|April 30, 2023
Comprehensive coverage on anti-mycobacterial endeavour reported during 2022Tejas M Dhameliya, Drashtiben D Vekariya, Heta Y Patel, et al.
Archiv Der Pharmazie|December 12, 2025
Recent Advancements and Developments of Anti-Malarial Agents Reported in 2023Palak K Vadodariya, Shahnaz Alom, Anu Sharma, et al.
Future Medicinal Chemistry|November 29, 2022
Benzo[<i>d</i>]thiazole-2-carboxamides as new antituberculosis chemotypes inhibiting mycobacterial ATP phosphoribosyl transferaseTejas M Dhameliya, Rishu Tiwari, Arkaprabha Banerjee, et al.
Pageof 3